260 related articles for article (PubMed ID: 31182245)
1. Poly(ADP-Ribosylation) in Age-Related Neurological Disease.
McGurk L; Rifai OM; Bonini NM
Trends Genet; 2019 Aug; 35(8):601-613. PubMed ID: 31182245
[TBL] [Abstract][Full Text] [Related]
2. Nuclear poly(ADP-ribose) activity is a therapeutic target in amyotrophic lateral sclerosis.
McGurk L; Mojsilovic-Petrovic J; Van Deerlin VM; Shorter J; Kalb RG; Lee VM; Trojanowski JQ; Lee EB; Bonini NM
Acta Neuropathol Commun; 2018 Aug; 6(1):84. PubMed ID: 30157956
[TBL] [Abstract][Full Text] [Related]
3. New insights of poly(ADP-ribosylation) in neurodegenerative diseases: A focus on protein phase separation and pathologic aggregation.
Liu C; Fang Y
Biochem Pharmacol; 2019 Sep; 167():58-63. PubMed ID: 31034795
[TBL] [Abstract][Full Text] [Related]
4. Poly(ADP-Ribose) Prevents Pathological Phase Separation of TDP-43 by Promoting Liquid Demixing and Stress Granule Localization.
McGurk L; Gomes E; Guo L; Mojsilovic-Petrovic J; Tran V; Kalb RG; Shorter J; Bonini NM
Mol Cell; 2018 Sep; 71(5):703-717.e9. PubMed ID: 30100264
[TBL] [Abstract][Full Text] [Related]
5. Genetic and pharmacological PARP inhibition reduces axonal degeneration in C. elegans models of ALS.
Tossing G; Livernoche R; Maios C; Bretonneau C; Labarre A; Parker JA
Hum Mol Genet; 2022 Sep; 31(19):3313-3324. PubMed ID: 35594544
[TBL] [Abstract][Full Text] [Related]
6. ADP-Ribosylation as Post-Translational Modification of Proteins: Use of Inhibitors in Cancer Control.
Poltronieri P; Miwa M; Masutani M
Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639169
[TBL] [Abstract][Full Text] [Related]
7. [Poly adenosine diphosphate-ribosylation and neurodegenerative diseases].
Wang Y; Lu Y
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2020 May; 49(1):100-106. PubMed ID: 32621411
[TBL] [Abstract][Full Text] [Related]
8. Poly(ADP-ribose) Engages the TDP-43 Nuclear-Localization Sequence to Regulate Granulo-Filamentous Aggregation.
McGurk L; Gomes E; Guo L; Shorter J; Bonini NM
Biochemistry; 2018 Dec; 57(51):6923-6926. PubMed ID: 30540446
[TBL] [Abstract][Full Text] [Related]
9. Poly (ADP-ribose) (PAR)-dependent cell death in neurodegenerative diseases.
Park H; Kam TI; Dawson TM; Dawson VL
Int Rev Cell Mol Biol; 2020; 353():1-29. PubMed ID: 32381174
[TBL] [Abstract][Full Text] [Related]
10. Poly(ADP-ribosylation) and neurodegenerative disorders.
Basello DA; Scovassi AI
Mitochondrion; 2015 Sep; 24():56-63. PubMed ID: 26196946
[TBL] [Abstract][Full Text] [Related]
11. PARPs and PAR as novel pharmacological targets for the treatment of stress granule-associated disorders.
Grimaldi G; Catara G; Palazzo L; Corteggio A; Valente C; Corda D
Biochem Pharmacol; 2019 Sep; 167():64-75. PubMed ID: 31102582
[TBL] [Abstract][Full Text] [Related]
12. Enabling drug discovery for the PARP protein family through the detection of mono-ADP-ribosylation.
Lu AZ; Abo R; Ren Y; Gui B; Mo JR; Blackwell D; Wigle T; Keilhack H; Niepel M
Biochem Pharmacol; 2019 Sep; 167():97-106. PubMed ID: 31075269
[TBL] [Abstract][Full Text] [Related]
13. Regulation of Biomolecular Condensates by Poly(ADP-ribose).
Rhine K; Odeh HM; Shorter J; Myong S
Chem Rev; 2023 Jul; 123(14):9065-9093. PubMed ID: 37115110
[TBL] [Abstract][Full Text] [Related]
14. Catching mono- and poly-ADP-ribose readers with synthetic ADP-ribose baits.
Cohen MS
Mol Cell; 2021 Nov; 81(21):4351-4353. PubMed ID: 34739826
[TBL] [Abstract][Full Text] [Related]
15. Generating Protein-Linked and Protein-Free Mono-, Oligo-, and Poly(ADP-Ribose) In Vitro.
Lin KY; Huang D; Kraus WL
Methods Mol Biol; 2018; 1813():91-108. PubMed ID: 30097863
[TBL] [Abstract][Full Text] [Related]
16. PARkinson's: From cellular mechanisms to potential therapeutics.
Lengyel-Zhand Z; Puentes LN; Mach RH
Pharmacol Ther; 2022 Feb; 230():107968. PubMed ID: 34391789
[TBL] [Abstract][Full Text] [Related]
17. Differential and Concordant Roles for Poly(ADP-Ribose) Polymerase 1 and Poly(ADP-Ribose) in Regulating WRN and RECQL5 Activities.
Khadka P; Hsu JK; Veith S; Tadokoro T; Shamanna RA; Mangerich A; Croteau DL; Bohr VA
Mol Cell Biol; 2015 Dec; 35(23):3974-89. PubMed ID: 26391948
[TBL] [Abstract][Full Text] [Related]
18. Fused in Sarcoma: Properties, Self-Assembly and Correlation with Neurodegenerative Diseases.
Chen C; Ding X; Akram N; Xue S; Luo SZ
Molecules; 2019 Apr; 24(8):. PubMed ID: 31022909
[TBL] [Abstract][Full Text] [Related]
19. Small-Molecule Inhibitors of PARPs: From Tools for Investigating ADP-Ribosylation to Therapeutics.
Kirby IT; Cohen MS
Curr Top Microbiol Immunol; 2019; 420():211-231. PubMed ID: 30242511
[TBL] [Abstract][Full Text] [Related]
20. Host poly(ADP-ribose) polymerases (PARPs) in acute and chronic bacterial infections.
Miettinen M; Vedantham M; Pulliainen AT
Microbes Infect; 2019 Dec; 21(10):423-431. PubMed ID: 31207286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
